Close
Nordic 9Nordic 9

Catalio Capital Management (investor - Venture Capital)

United States cataliocapital.com
See something wrong or missing? Let us know
Offices:Baltimore

Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies

Average round investment:124.67M USD
Average number per year:1.5
Distribution: 2025 (2)2024 (1)2023 (1)2021 (2)
Portfolio companies: United Kingdom Leo Cancer CareSwitzerland GlycoEraSwitzerland Alentis Therapeutics See the entire list
Mostly invests in: Switzerland Switzerland (3) Health services (6)
See the entire list

Showing 3 of 6 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Catalio Capital Management

Name Criteria
Singapore ABC World
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Canada Investissement Québec
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland, United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
France Noteus Partners
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Financial Services, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom HgCapital
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Hardware, Financial Services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, France, Germany
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Switzerland Partners Group
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Financial Services, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Switzerland, France, Germany
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Liechtenstein LGT
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Manufacturing, Financial Services, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Germany KfW
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
South Korea LG Electronics
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, France, Germany
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Netherlands APG Asset Management
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Biotech, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Eric Schmidt
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top